Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

BACKGROUND: To assess the tardive dyskinesia (TD) rate in studies of once-monthly long-acting injectable (LAI) paliperidone palmitate (PP) and once-daily oral paliperidone extended release (Pali ER). METHODS: Completed schizophrenia and bipolar studies for PP and Pali ER (≥ 6 month duration with ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopal, S, Xu, H, Bossie, C, Burón, J A, Fu, D J, Savitz, A, Nuamah, I, Hough, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265240/
https://www.ncbi.nlm.nih.gov/pubmed/25358867
http://dx.doi.org/10.1111/ijcp.12493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265240/
https://www.ncbi.nlm.nih.gov/pubmed/25358867
http://dx.doi.org/10.1111/ijcp.12493

Ejemplares similares